Navigation Links
Cellular Biomedicine Group Announces Completion of Patient Treatment for Phase I/IIa Clinical Trial for Treatment of Knee Osteoarthritis (KOA)
Date:11/1/2013

PALO ALTO, Calif., Nov. 1, 2013 /PRNewswire/ -- Cellular Biomedicine Group, Inc. (OTCQB: CBMG) is pleased to announce that it has treated the final patient of its Phase I/IIa clinical trial for ReJoin™, a human adipose-derived mesenchymal precursor cell (haMPC) therapy for Knee Osteoarthritis (KOA). The trial tests the safety and efficacy of intra-articular injections of autologous (patient's own) haMPCs in order to reduce inflammation and repair damaged joint cartilage.

The clinical trial is conducted by Shanghai's Renji Hospital, a tertiary hospital affiliated with Shanghai Jiao Tong University School of Medicine. As previously reported, the interim analysis of the trial demonstrated that patients had a clinically meaningful reduction in pain and increase in mobility, with a significant improvement (P<0.05) from the baseline in clinical scores for SF-36, NRS-11, and WOMAC osteoarthritis indices, and no serious adverse events were reported for the duration of the trial.

Full data analysis by FuDan Medical University Department of Biostatistics will be carried out in the next four to six weeks and the final report of the trial will be announced before the end of the year.

About Cellular Biomedicine Group
Cellular Biomedicine Group, Inc. develops proprietary cell therapies for the treatment of certain degenerative diseases and cancers.  Our developmental stem cell, progenitor cell, and immune cell projects are the result of research and development by scientists and doctors from China and the United States. Our flagship GMP facility, consisting of eight independent cell production lines, is designed, certified and
'/>"/>

SOURCE Cellular Biomedicine Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Cellular Biomedicine Group Announces New Product Approved for Market in China and New Exclusive License
2. Cellular Biomedicine Group Reports Second Quarter and First Half 2013 Financial Results and Business Highlights
3. Decellularized mouse heart beats again after regenerating with human heart precursor cells
4. Cellular Dynamics International Announces Launch of Initial Public Offering
5. Cellular Biomedicine Group Announces Expansion in the Osteoarthritis and Rheumatoid Arthritis Market
6. Cellular Therapy and Cord Blood 2013 Market Report
7. Cellular Biomedicine Group Announces Appointment of Corporate Controller
8. Cellular Dynamics International Expands MyCell Products Line with Disease Models, Genetic Engineering Patents
9. Cellular Dynamics International Files Registration Statement for Proposed Initial Public Offering
10. Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis
11. Intra-Cellular Therapies Appoints Professor Sir Michael Rawlins to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... Skeletal dysplasia is a group of rare diseases ... and cartilage. Its onset hits at the fetal ... mutation in the gene encoding fibroblast growth factor ... types of skeletal dysplasia, thanatophoric dysplasia (TD), a ... birth and is often lethal, and achondroplasia (ACH), ...
(Date:9/18/2014)... loss and diabetes prevention, could actually hasten the development ... it in a surprising way: by changing the composition ... population of bacteria residing in our intestines. These findings, ... published today in Nature . Among other things, ... Department, who led this research together with Prof. Eran ...
(Date:9/18/2014)... everything we touch in the course of a ... even medicines, rely on the chemical industry to ... and farm products into valuable chemicals that are ... scientist Dr Sarina Sarina, who achieved outstanding progress ... at ambient temperature using light instead of fossil ...
(Date:9/18/2014)... 2014 Silicon-valley Electronic Data Capture (EDC) ... TXT , the latest addition to Clinovo’s CRO Partnership ... Organization (CRO) Program, Clinovo further expands its global reach ... ClinCapture training, we are now able to build studies ... “We can also rely on Clinovo to fully support ...
Breaking Biology Technology:Researchers use iPS cells to show statin effects on diseased bone 2Researchers use iPS cells to show statin effects on diseased bone 3Gut bacteria, artificial sweeteners and glucose intolerance 2Gut bacteria, artificial sweeteners and glucose intolerance 3Using solar energy to turn raw materials into ingredients for every day life 2Digitaliza TXT Joins Clinovo’s CRO Partnership Program, Bringing Its Open Source EDC System, ClinCapture to Latin America 2Digitaliza TXT Joins Clinovo’s CRO Partnership Program, Bringing Its Open Source EDC System, ClinCapture to Latin America 3
... Regulus Therapeutics Inc ., a biopharmaceutical company leading the ... announced that it has identified a third microRNA target ... milestone payment from GSK. This selection represents another significant ... which is focused on the discovery and development of ...
... , Daval International announced the ... double blind Phase II,Study, Treating Patients with Bladder ... Standard clinical,measures and assessment scores recorded on patients ... be used to investigate safety,efficacy and response to ...
... ReSearch Pharmaceutical Services, Inc. (RPS), a next ... clinical development solutions to the biopharmaceutical and medical ... to its Operational and Senior Management team.   ... Chief Information Officer and Executive Vice President, Clinical ...
Cached Biology Technology:Regulus Therapeutics and GlaxoSmithKline Name a Third Alliance microRNA Target Triggering a Preclinical Milestone Payment 2Regulus Therapeutics and GlaxoSmithKline Name a Third Alliance microRNA Target Triggering a Preclinical Milestone Payment 3Regulus Therapeutics and GlaxoSmithKline Name a Third Alliance microRNA Target Triggering a Preclinical Milestone Payment 4Daval International Announces Completion of Phase II Trial for the Treatment of Bladder Dysfunction With AIMSPRO® in Secondary Progressive Multiple Sclerosis 2Daval International Announces Completion of Phase II Trial for the Treatment of Bladder Dysfunction With AIMSPRO® in Secondary Progressive Multiple Sclerosis 3RPS Continues Expansion of Global Clinical, Regulatory, Medical, and Operational Leadership 2RPS Continues Expansion of Global Clinical, Regulatory, Medical, and Operational Leadership 3
(Date:9/17/2014)... of Oncology-Bellvitge Biomedical Research Institute (ICO-IDIBELL), led by ... in normal accompanying cells in colorectal tumors. Analysis ... colorectal tumors, predict the evolution of the patient ... relapses. , Biomarkers , Colorectal ... considering both sexes. About 30,000 new cases are ...
(Date:9/17/2014)... growing significantly faster since the 1960s. The typical development ... they have accelerated -- by as much as 70 ... out by scientists from Technische Universitt Mnchen based on ... continuously observed since 1870. Their findings were published recently ... "forest dieback" was a hot topic, with the very ...
(Date:9/16/2014)... The risk of severe maternal morbidity amongst women ... suggests a new study published today (17 September) ... and Gynaecology . , Australians generally enjoy high ... that health disparities exist, in particular between indigenous ... aimed to explore the independent impact of socioeconomic ...
Breaking Biology News(10 mins):Five genes to predict colorectal cancer relapses 2Global change: Trees continue to grow at a faster rate 2Global change: Trees continue to grow at a faster rate 3New study examines the impact of socioeconomic position & maternal morbidity in Australia 2New study examines the impact of socioeconomic position & maternal morbidity in Australia 3
... be difficult for a terrorist to obtain genes from the ... Armed with a fake email address, a would-be bioterrorist could ... online, and receive them by post within weeks. , That's ... the bioterror risks posed by the booming business of gene ...
... students have discovered the antler of an Irish Elk in cliffs ... the exact age of the antler has yet to be determined, ... lived around 11,000 years ago. The giant deer roamed the open ... of the last Ice Age, as the glaciers retreated northwards. ...
... Medical Institute researchers have discovered that pheromones essential for ... and not by the vomeronasal system, as researchers had ... epithelium, which was presumed to be mostly involved with ... pheromone detection. , Howard Hughes Medical Institute investigator ...
Cached Biology News:The bioweapon is in the post 2The bioweapon is in the post 3The bioweapon is in the post 4Students discover 11,000 year old remains of Irish Elk 2Olfactory system detects pheromones that control reproduction 2Olfactory system detects pheromones that control reproduction 3Olfactory system detects pheromones that control reproduction 4
TEMPLIPHI HT SEQ AMPL KIT, 1 EA. Category: Sequencing Template Amplification....
This Malachite Green Phosphate Detection Kit...
Request Info...
1+ mg expected yield of purified protein, expressed in insect cells - excludes cDNA...
Biology Products: